De La Cruz Castor Oil
NDC Package 24286-1526-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

De La Cruz Castor Oil (castor oil) oils is preferably taken on an empty stomach.May be taken with juice to improve the taste.AgeDoseAdults and children 12 years and over1 to 4 tablespoons in a single daily dose or as directed by a doctorChildren 2 to under 12 years1 to 3 teaspoons in a single daily dose or as directed by a doctorChildren under 2 yearsConsult a doctor. This formulation utilizes a oil delivery system. Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1526 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
24286-1526-9
Package Description
236 mL in 1 BOTTLE, GLASS
Product Code
24286-1526
11-Digit Billing Format
24286152609
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
De La Cruz Castor Oil
Non-Proprietary Name
Castor Oil
Substance Name
Castor Oil
Dosage Form
Oil - An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CASTOR OIL 1 g/mL
Usage Information
Preferably taken on an empty stomach.May be taken with juice to improve the taste.AgeDoseAdults and children 12 years and over1 to 4 tablespoons in a single daily dose or as directed by a doctorChildren 2 to under 12 years1 to 3 teaspoons in a single daily dose or as directed by a doctorChildren under 2 yearsConsult a doctor

Regulatory & Marketing

Labeler Name
Dlc Laboratories, Inc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-27-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24286-1526). Click a package code to view its specific billing and regulatory data.

24286-1526-1
473 mL in 1 BOTTLE
24286-1526-5
59 mL in 1 BOTTLE
24286-1526-8
236 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24286-1526-9 identifies a specific commercial package of 236 ml in 1 bottle, glass of De La Cruz Castor Oil, a human over the counter drug labeled by Dlc Laboratories, Inc.. This oil is formulated for oral use and contains castor oil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc. on July 27, 2012. The current certification is valid through December 31, 2026.

How is this Dlc Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286152609. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
24286-1526-9
11-Digit CMS (5-4-2)
24286-1526-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.